文献速递心外重症与机械循环支持

儿科心室辅助装置支持:单中心二十年经验

Ventricular Assist Device Support: Single Pediatric Institution Experience Over Two Decades.
PubMed 文献 · Ann Thorac Surg · 2018-10-06

该研究回顾性分析了1996至2017年间单中心159例儿科患者共201例心室辅助装置(VAD)支持的经验,其中临时支持82例(41%),持久支持119例(59%)。临时支持者80%获得积极结局,以桥接恢复(53%)和桥接至另一种VAD(38%)为主;持久支持者84%获得积极结局,以桥接移植(66%)为主。研究期间最显著的变化是植入式连续流VAD的应用,使门诊管理成为常规。

要点

  • 临时VAD支持者80%获积极结局,以桥接恢复和桥接至另一种VAD为主。
  • 持久VAD支持者84%获积极结局,桥接移植为主要终点。
  • 植入式连续流VAD引入后,2013年后85%患者可带装置出院。

核心结论

  • 过去二十年儿科VAD支持发生演变,植入式连续流VAD的应用使门诊管理成为常规并影响临床结局。

研究设计与样本

  • 单中心回顾性研究,纳入1996至2017年接受VAD支持的儿科患者,共159例患者植入201个VAD。

主要发现

  • 临时支持82例(41%),持久支持119例(59%),年度植入量呈增长趋势。
  • 临时支持积极结局80%(66/82),桥接恢复53%(35/66),桥接至另一种VAD 38%(25/66)。
  • 持久支持积极结局84%(100/119),桥接移植66%(78/119)为主要终点。
  • 2004年前无患者带VAD出院,2013年后85%患者带具有出院能力的VAD出院。

关键数值与推荐

  • 积极结局包括桥接移植、桥接恢复、带装置存活和桥接至另一种VAD;消极结局包括VAD支持期间死亡或桥接恢复后院内死亡。
  • 不良事件分类采用儿科机械循环支持机构间登记(Pediatric Interagency Registry for Mechanical Circulatory Support)定义。

临床怎么用

  • 儿科VAD支持中临时与持久装置的选择影响结局,植入式连续流VAD使门诊管理可行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We reviewed our single institutional experience with pediatric ventricular assist device (VAD) support over the last 2 decades, with an aim to improve our current management and gain an insight into the future direction. METHODS: A retrospective review was conducted on all patients that had undergone VAD support between 1996 and 2017. Outcomes were analyzed based on the type of VADs, whether temporary or durable devices. Primary end points were positive outcomes, including bridge-to-transplantation, bridge-to-recovery, alive on device, and bridge-to-bridge to another VAD, or negative outcomes, including death during VAD support or in-hospital death after bridge-to-recovery. The Pediatric Interagency Registry for Mechanical Circulatory Support definition was used to classify adverse events. RESULTS: Overall, 201 VADs were implanted in 159 patients, with 82 (41%) and 119 (59%) being temporary and durable support, respectively. There has been a trend toward an increasing annual implant volume both with temporary and durable VADs. Positive outcomes were achieved in 80% (66 of 82) of those with temporary support, with bridge-to-recovery (53% [35 of 66]) and bridge-to-bridge to another VAD (38% [25 of 66]) being the predominant outcomes. Of those on durable support, 84% (100 of 119) achieved positive outcomes, with bridge-to-transplant (66% [78 of 119]) being the leading destination. The most notable change during the study period was the introduction of implantable continuous-flow VADs, resulting in outpatient management becoming a routine practice. No patients were discharged on VAD support before 2004, but 85% were discharged on VADs with discharge capability after 2013. CONCLUSIONS: The present study has demonstrated the evolutional changes of pediatric VAD support and their effect on clinical outcomes over the last 2 decades.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Fraser CD, Chacon-Portillo MA, Zea-Vera R, et al. Ventricular Assist Device Support: Single Pediatric Institution Experience Over Two Decades. Ann Thorac Surg. 2018. PMID: 30296425. doi:10.1016/j.athoracsur.2018.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。